The prognosis of <i>MYC</i> translocation positive diffuse large B‐cell lymphoma depends on the second hit
Alexandra Clipson(Cancer Research UK), Ming‐Qing Du(MRC Laboratory of Molecular Biology), John R. Goodlad(National Health Service), George Follows(Addenbrooke's Hospital), Sharon Barrans(Leeds Teaching Hospitals NHS Trust), Simon Crouch(University of York), Eve Roman(University of York), Lisa Worrillow(St James's University Hospital), Penny Wright(Canterbury Health Laboratories), Sylvia Kocialkowski(University of Cambridge), Nicholas F. Grigoropoulos(University of Cambridge), Andrew Jack(University of Alberta), James Watkins(Cambridge University Hospitals NHS Foundation Trust), Michael Neat(Guy's Hospital), Jenny Buxton(Western General Hospital), Paul Fields(Guy's Hospital), Ming Wang(Wenzhou Medical University), Hongxiang Liu(Cambridge University Hospitals NHS Foundation Trust), Yuanxue Huang(Cambridge University Hospitals NHS Foundation Trust), John W. Grant(Cambridge University Hospitals NHS Foundation Trust), Bridget S. Wilkins(Royal Victoria Infirmary), Naiyan Zeng(Shanghai Jiao Tong University), Hesham EIDaly(Cambridge University Hospitals NHS Foundation Trust), Peter Johnson(Cancer Research UK)
Cited by 62
Related Papers
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
|The Lancet Neurology|2012|606
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2008|605